Ben Creelan: Three Big Milestones in Cancer Cell Therapy
Ben Creelan, Thoracic Oncologist at Moffitt Cancer Center, shared a post on X: “Three big milestones for cell therapy in ca this past month: First CAR-T approved in China for gastric ca […]
Read the full articleYou might also wanna read
AbClon Wins U.S. Patent for CD30 CAR-T Therapy Developed with UPenn
AbClon has won final U.S. patent registration from the USPTO for CD30-targeting CAR-T therapy, developed jointly with the University of Penn
China approves world's first CAR-T cell therapy for solid tumors: CARsgen's satri-cel for advanced gastric cancer
The gastric cancer treatment proves engineered cellular therapies can treat solid tumors.
insideprecisionmedicine.com·15d agoCancerNetwork: Illuminating Optimal CAR T-Cell Therapies Across Large B-Cell Lymphoma Groups
The post CancerNetwork: Illuminating Optimal CAR T-Cell Therapies Across Large B-Cell Lymphoma Groups appeared first on UNC Lineberger Compr
CAR T Revolutionized How We Treat Blood Cancers. Now It’s Closing In on Solid Tumors.
Separate teams discovered the same target in solid cancers, enabling a powerful two-pronged attack on both tumors and the cells shielding th
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
An AI-guided framework integrating high-resolution cellular atlases, public knowledge databases, and large language models enables a modular
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
The country’s new regulatory pathway promises to accelerate access to advanced therapies for Chinese patients, but may change the licensing
biopharmadive.com·26d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.